CHEMOTHERAPY IN COMBINED MODALITY TREATMENT FOR LOCALLY ADVAMCED NON-SMALL CELL LUNG CANCER
Abstract
About the Authors
Е. L. YumovRussian Federation
12/1 Savinykh Street, 634028-Toms
S. V. Miller
Russian Federation
12/1 Savinykh Street, 634028-Toms
N. V. Litvyakov
Russian Federation
12/1 Savinykh Street, 634028-Toms
Т. V. Polischuk
Russian Federation
12/1 Savinykh Street, 634028-Toms
S. А. Tuzikov
Russian Federation
12/1 Savinykh Street, 634028-Toms
О. V. Cheremisina
Russian Federation
12/1 Savinykh Street, 634028-Toms
V. Е. Goldberg
Russian Federation
12/1 Savinykh Street, 634028-Toms
Е. О. Rodionov
Russian Federation
12/1 Savinykh Street, 634028-Toms
References
1. Laktionov K.K., Davydov M.I., Polockij B.E., Zborovskaja I.B., Bogatyrev V.N., Nikulichev L.A., Stepanova E.V., Allahverdiev A.K., Ardzinba M.S. Prognostic and predicting factors in patients with non-small cell lung cancer // Prakticheskaja onkologija. 2006. Vol. 7 (3). P. 145–153. [in Russian]
2. Miller S.V., Tuzikov S.A., Gol’dberg V.E., Zav’jalov A.A., Polishhuk T.V., Dobrodeev A.Ju., Jumov E.L., Lobykin A.F. Neoadjuvant chemotherapy with taxanes in combined modality treatment of non-small cell lung cancer // Rossijskij onkologicheskij zhurnal. 2011. № 5. P. 4–8. [in Russian]
3. Trahtenberg A.H., Chissov V.I. Clinical oncopulmonogy. M.: Medicina, 2000. 599 p. [in Russian]
4. Chissov V.I., Starinskij V.V., Petrova G.V. Cancer incidence in Russia in 2011 (morbidity and mortality). M., 2013. 289 p. [in Russian]
5. D’Amato T.A., Landreneau R.J., McKenna R.J., Santos R.S., Parker R.J. Prevalence of in vitro extreme chemotherapy resistance in resected non small-cell lung cancer // Ann. Thorac. Surg. 2006. Vol. 81. P. 440–447. [in Russian]
6. Evans N.R., Li S., Wright C.D., Wright C.D., Allen M.S., Gaissert H.A. The impact of induction therapy on morbidity and operative mortality after resection of primary lung cancer // J. Thorac. Cardiovasc. Surg. 2010. Vol. 139 (4). P. 991–996. doi: 10.1016/j.jtcvs.2009.11.070.
7. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C.D., Parkin D. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer; Year. Available at: http://globocan.iarc.fr. 2010.
8. Gilligan D., Nicolson M., Smith I., Groen H., Dalesio O., Goldstraw P., Hatton M., Hopwood P., Manegold C., Schramel F., Smit H., van Meerbeeck J., Nankivell M., Parmar M., Pugh C., Stephens R. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVaLT2/EORTC 08012 multicentre randomised trial and update of systematic review // Lancet. 2007. Vol. 369. P. 1929–1937.
9. Giuliani J., Piacentini P., Greco F., Mercanti A., Trolese A.R., Furini L., Durante E., Moratello G., Tognetto M., Bonetti A. Carboplatin-containing regimens as front-line treatment for advanced nonsmall-cell lung cancer in two groups of elderly // J. Chemother. 2014. Vol. 26 (2). P. 111–116. doi: 10.1179/1973947813Y.0000000112.
10. Kolek V., Grygarkova I., Hajduch M., Klein J., Cwiertka K., Neoral C., Langova K., Mihal V. Long term follow-up of neoadjuvant-adjuvant combination treatment of IIIA stage non-small-cell-lung cancer: results of neoadjuvant carboplatin/vinorelbine and carboplatin/paclitaxel regimens combined with selective adjuvant chemotherapy according to in-vitro chemoresistance test // Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub. 2008. Vol. 152 (2). P. 259–266.
11. Sato Y., Yamamoto N., Kunitoh H., Ohe Y., Minami H., Laird N.M., Katori N., Saito Y., Ohnami S., Sakamoto H., Sawada J., Saijo N., Yoshida T., Tamura T. Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel // J. Thorac. Oncol. 2011. Vol. 6 (1). P. 132–138. doi: 10.1097/ JTO.0b013e318200f415.
12. Scagliotti G.V., Pastorino U., Vansteenkiste J.F., Spaggiari L., Facciolo F., Orlowski T.M., Maiorino L., Hetzel M., Leschinger M., Visseren-Grul C., Torri V. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIa non-small-cell lung cancer // J. Clin. Oncol. 2012. Vol. 30. P. 172–178. doi: 10.1200/JCO.2010.33.7089.
Review
For citations:
Yumov Е.L., Miller S.V., Litvyakov N.V., Polischuk Т.V., Tuzikov S.А., Cheremisina О.V., Goldberg V.Е., Rodionov Е.О. CHEMOTHERAPY IN COMBINED MODALITY TREATMENT FOR LOCALLY ADVAMCED NON-SMALL CELL LUNG CANCER. Siberian journal of oncology. 2014;(2):9-13. (In Russ.)